Marchetti, C., Fagotti, A., Fruscio, R., Cassani, C., Incorvaia, L., Perri, M.T., et al. (2025). Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response. ESMO OPEN, 10(6) [10.1016/j.esmoop.2025.105299].
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response
Marchetti, C;Incorvaia, L;Giudice, E;Russo, A;
2025-06-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Letter_1.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
164.47 kB
Formato
Adobe PDF
|
164.47 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
